GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bal Pharma Ltd (NSE:BALPHARMA) » Definitions » E10

Bal Pharma (NSE:BALPHARMA) E10 : ₹1.64 (As of Dec. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Bal Pharma E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Bal Pharma's adjusted earnings per share data for the three months ended in Dec. 2024 was ₹0.330. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹1.64 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Bal Pharma's average E10 Growth Rate was -12.20% per year. During the past 3 years, the average E10 Growth Rate was -13.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Bal Pharma was -13.80% per year. The lowest was -13.80% per year. And the median was -13.80% per year.

As of today (2025-03-30), Bal Pharma's current stock price is ₹83.90. Bal Pharma's E10 for the quarter that ended in Dec. 2024 was ₹1.64. Bal Pharma's Shiller PE Ratio of today is 51.16.

During the past 13 years, the highest Shiller PE Ratio of Bal Pharma was 77.39. The lowest was 16.70. And the median was 42.52.


Bal Pharma E10 Historical Data

The historical data trend for Bal Pharma's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bal Pharma E10 Chart

Bal Pharma Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 3.30 2.66 2.36 2.11

Bal Pharma Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.87 2.11 1.93 1.81 1.64

Competitive Comparison of Bal Pharma's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Bal Pharma's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bal Pharma's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bal Pharma's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Bal Pharma's Shiller PE Ratio falls into.


;
;

Bal Pharma E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bal Pharma's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.33/158.3229*158.3229
=0.330

Current CPI (Dec. 2024) = 158.3229.

Bal Pharma Quarterly Data

per share eps CPI Adj_EPS
201406 0.780 94.103 1.312
201409 1.320 96.780 2.159
201412 0.810 96.780 1.325
201503 0.090 97.163 0.147
201506 -0.240 99.841 -0.381
201509 1.520 101.753 2.365
201512 1.520 102.901 2.339
201603 -2.033 102.518 -3.140
201606 0.040 105.961 0.060
201609 0.120 105.961 0.179
201612 0.430 105.196 0.647
201703 -1.290 105.196 -1.941
201803 -0.130 109.786 -0.187
201806 1.120 111.317 1.593
201809 -0.530 115.142 -0.729
201812 1.120 115.142 1.540
201903 2.070 118.202 2.773
201906 -1.620 120.880 -2.122
201909 -1.290 123.175 -1.658
201912 -2.518 126.235 -3.158
202003 -3.210 124.705 -4.075
202006 0.300 127.000 0.374
202009 0.300 130.118 0.365
202012 0.280 130.889 0.339
202103 2.510 131.771 3.016
202106 1.090 134.084 1.287
202109 0.970 135.847 1.130
202112 0.320 138.161 0.367
202203 1.416 138.822 1.615
202206 0.930 142.347 1.034
202209 0.070 144.661 0.077
202212 0.380 145.763 0.413
202303 1.030 146.865 1.110
202306 0.060 150.280 0.063
202309 0.620 151.492 0.648
202312 0.540 152.924 0.559
202403 3.730 153.035 3.859
202406 0.160 155.789 0.163
202409 0.650 157.882 0.652
202412 0.330 158.323 0.330

Add all the adjusted EPS together and divide 10 will get our e10.


Bal Pharma  (NSE:BALPHARMA) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Bal Pharma's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=83.90/1.64
=51.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Bal Pharma was 77.39. The lowest was 16.70. And the median was 42.52.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Bal Pharma E10 Related Terms

Thank you for viewing the detailed overview of Bal Pharma's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Bal Pharma Business Description

Traded in Other Exchanges
Address
10/1, Palace Road, 5th Floor, Lakshmi Narayan Complex, Bengaluru, KA, IND, 560052
Bal Pharma Ltd is a pharmaceutical company. It is principally engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients. The company specializes in prescription drugs, generic and over-the-counter products, intravenous infusion, and bulk actives. It offers products in dosage forms, such as tablets, capsules, syrups, suspensions, creams, and ointments, to various markets.

Bal Pharma Headlines

No Headlines